206 related articles for article (PubMed ID: 32378663)
1. [Development of Nano-DDS Carriers for Control of Spatial Distribution Using Multi-color Deep Imaging].
Kawakami S; Suga T
Yakugaku Zasshi; 2020; 140(5):633-640. PubMed ID: 32378663
[TBL] [Abstract][Full Text] [Related]
2. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
[TBL] [Abstract][Full Text] [Related]
3. [Development of New Liposome Targeting Strategies for Application of Disease Therapies].
Shimizu K
Yakugaku Zasshi; 2017; 137(1):43-48. PubMed ID: 28049894
[TBL] [Abstract][Full Text] [Related]
4. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
Oku N
Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
[TBL] [Abstract][Full Text] [Related]
5. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
Saravanakumar K; Hu X; Ali DM; Wang MH
Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery to the intestinal lymph by oral formulations.
Yoshida T; Kojima H; Sako K; Kondo H
Pharm Dev Technol; 2022 Feb; 27(2):175-189. PubMed ID: 35037843
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer.
Allen TM; Cheng WW; Hare JI; Laginha KM
Anticancer Agents Med Chem; 2006 Nov; 6(6):513-23. PubMed ID: 17100556
[TBL] [Abstract][Full Text] [Related]
8. Development of a Screening System for Targeting Carriers Using Peptide-Modified Liposomes and Tissue Sections.
Negishi Y; Hamano N; Sato H; Katagiri F; Takatori K; Endo-Takahashi Y; Kikkawa Y; Nomizu M
Biol Pharm Bull; 2018; 41(7):1107-1111. PubMed ID: 29962407
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery systems: entering the mainstream.
Allen TM; Cullis PR
Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
[TBL] [Abstract][Full Text] [Related]
10. Drug transport kinetics of intravascular triggered drug delivery systems.
Ten Hagen TLM; Dreher MR; Zalba S; Seynhaeve ALB; Amin M; Li L; Haemmerich D
Commun Biol; 2021 Jul; 4(1):920. PubMed ID: 34321602
[TBL] [Abstract][Full Text] [Related]
11. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
Nakamura T
Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
[TBL] [Abstract][Full Text] [Related]
12. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
[TBL] [Abstract][Full Text] [Related]
15. Liposomes in biology and medicine.
Schwendener RA
Adv Exp Med Biol; 2007; 620():117-28. PubMed ID: 18217339
[TBL] [Abstract][Full Text] [Related]
16. Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies.
Alkaff SA; Radhakrishnan K; Nedumaran AM; Liao P; Czarny B
Int J Nanomedicine; 2020; 15():445-464. PubMed ID: 32021190
[TBL] [Abstract][Full Text] [Related]
17. Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations.
Das RP; Gandhi VV; Singh BG; Kunwar A
Curr Pharm Des; 2019; 25(28):3034-3056. PubMed ID: 31470779
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances on Cellulose-Based Nano-Drug Delivery Systems: Design of Prodrugs and Nanoparticles.
Dai L; Si C
Curr Med Chem; 2019; 26(14):2410-2429. PubMed ID: 28699504
[TBL] [Abstract][Full Text] [Related]
19. Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview.
Liu X; Cheng Y; Mu Y; Zhang Z; Tian D; Liu Y; Hu X; Wen T
Front Immunol; 2024; 15():1328145. PubMed ID: 38298192
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the dynamics of drug delivery systems (DDS) using intravital real-time confocal laser scanning microscopy].
Nomoto T; Matsumoto Y; Toh K; Christie RJ; Miyata K; Oba M; Cabral H; Murakami M; Fukushima S; Nishiyama N; Kataoka K
Yakugaku Zasshi; 2012; 132(12):1347-54. PubMed ID: 23208040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
